2024 Annual Gateway Conference
Logotype for Flotek Industries Inc

Flotek Industries (FTK) 2024 Annual Gateway Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for Flotek Industries Inc

2024 Annual Gateway Conference summary

3 Feb, 2026

Strategic turnaround and business model evolution

  • Executed a multi-year turnaround plan focused on restoring the core chemistry business and expanding into data analytics, leveraging over 170 patents and a global presence in 59+ countries.

  • Achieved seven consecutive quarters of EBITDA improvement, supported by a $2 billion, ten-year take-or-pay agreement with a major pressure pumping company.

  • Maintained low leverage (0.4x EBITDA) and a clean balance sheet while expanding both chemistry and data analytics segments.

  • Raised 2024 guidance midpoint by 23% after a 150% year-on-year gross margin improvement from Q2 2023 to Q2 2024.

  • Data analytics business transitioned to a recurring revenue model, with over 60% of revenue from subscriptions and rapid growth expected to continue.

Technology differentiation and market impact

  • Proprietary Prescriptive Chemistry Management and machine learning applied to over 20,000 wells, delivering up to 30% production uplift in recent completions.

  • Market share in North American hydraulic fracturing chemistry grew from under 1% to nearly 17%, with a target of 25% in coming quarters.

  • Data analytics segment, including JP3 and Verax, provides real-time hydrocarbon measurement, improving transparency and asset performance.

  • EPA-approved VeriCal technology enables compliance with new flare monitoring regulations, opening a billion-dollar TAM with 55,000+ flare sites.

  • Real-time measurement solutions can prevent significant revenue loss for operators, with potential $6 million per well annual impact and industry-wide risk over $100 billion.

Growth strategy, scalability, and future outlook

  • Data analytics business expected to reach 70% subscription revenue by year-end, with strong order momentum ahead of regulatory deadlines.

  • Exploring joint ventures and channel partnerships to scale JP3 and Verax deployment, focusing on technology and software while partners handle field service.

  • Production chemistry segment offers high-margin, less cyclical revenue, with a $6 billion market opportunity and potential to add $300–600 million in revenue with modest share gains.

  • Anticipates industry cycle improvement in 2025–2026, with LNG exports and power generation driving demand.

  • Long-term vision targets $1 billion revenue and market cap, leveraging both chemistry and data analytics for sustainable growth.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more